Hostname: page-component-7b7567c8c-9cwtv Total loading time: 0 Render date: 2026-11-19T18:36:19.535Z Has data issue: false hasContentIssue false

Utility of hybrid whole genome sequencing in assessing potential nosocomial VIM transmission

Published online by Cambridge University Press:  05 August 2024

David Burke James Mahoney
Affiliation:
Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS, CanadaFaculty of Computer Science, Dalhousie University, Halifax, NS, Canada
Xena Li
Affiliation:
Shared Hospital Laboratory, Toronto, ON, CanadaSunnybrook Health Sciences Centre, Toronto, ON, CanadaInfection Prevention and Control, North York General Hospital, Toronto, ON, Canada
Patryk Aftanas
Affiliation:
Shared Hospital Laboratory, Toronto, ON, Canada
Christie Vermeiren
Affiliation:
Shared Hospital Laboratory, Toronto, ON, CanadaSunnybrook Health Sciences Centre, Toronto, ON, CanadaDepartment of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada
Robert Kozak
Affiliation:
Shared Hospital Laboratory, Toronto, ON, CanadaSunnybrook Health Sciences Centre, Toronto, ON, CanadaDepartment of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada
Kevin Katz
Affiliation:
Shared Hospital Laboratory, Toronto, ON, CanadaSunnybrook Health Sciences Centre, Toronto, ON, CanadaInfection Prevention and Control, North York General Hospital, Toronto, ON, CanadaDepartment of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada
Finlay Maguire*
Affiliation:
Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS, CanadaFaculty of Computer Science, Dalhousie University, Halifax, NS, CanadaShared Hospital Laboratory, Toronto, ON, CanadaSunnybrook Health Sciences Centre, Toronto, ON, Canada
*
Corresponding author: Finlay Maguire; Email: finlay.maguire@dal.ca

Abstract (narrative)

Hybrid whole genome sequencing was used to investigate if nosocomial Verona integron-encoded metallo-β-lactamase (VIM) carbapenemase transmission occurred between two patients without epidemiological links or common pathogens. Challenges in genomic methodology and appropriate analytical depth for mobile carbapenemase outbreaks are described including how inappropriate choices can mislead results and impact infection control practices.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1.Overview of mobile VIM genomic analysis results. A The annotated VIM-bearing plasmids assembled from each of the isolates. The VIM gene is highlighted in orange and identified integrons in the plasmids marked using a dark gray bar in the inner circle. B The alignment and comparison of the three VIM-bearing integrons. The vertical ribbons indicate genes with shared sequence identity between the integrons (as per the % identity scale bar). C A comparison of the VIM alleles in each taxa in the form of a truncated alignment showing all the sequence differences.

Figure 1

Figure 2.An overview of analyses and conflicting results during the investigation of a possible nosocomial transmission of a mobile VIM carbapenemase. Ticks and crosses (and associated box highlighting), respectively, represent information that supported or refuted potential linkage between patients.